Subjects: Drug Approval and Neoplasm, Residual - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Drug Approval ✖ Subjects Neoplasm, Residual ✖

1. Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment